DAVID STIDHAM: Open Payments
NPI 1700378049 · ADEL, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$659 in 30 payments from 10 companies in 2025. Trend: 2023 $783 · 2024 $604 · 2025 $659
Food & beverage: $659
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 7 | $135 |
| Alkermes, Inc. | 5 | $112 |
| Neurocrine BioSciences, Inc. | 4 | $105 |
| E.R. Squibb & Sons, L.L.C. | 4 | $78 |
| Janssen Pharmaceuticals, Inc | 2 | $49 |
| Shockwave Medical, Inc | 2 | $45 |
| Teva Pharmaceuticals USA, Inc. | 2 | $43 |
| ABBVIE INC. | 1 | $40 |
| Indivior Inc. | 2 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
Products named: FANAPT, INGREZZA, COBENFY, ARISTADA, INVEGA SUSTENNA, Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter, AUSTEDO XR, VRAYLAR.
Industry payments across GA — which companies pay providers there.
